189 related articles for article (PubMed ID: 18481277)
21. Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells.
Gao J; Isaacs JT
Cancer Res; 1998 Aug; 58(15):3299-306. PubMed ID: 9699659
[TBL] [Abstract][Full Text] [Related]
22. Prosaptide TX14A stimulates growth, migration, and invasion and activates the Raf-MEK-ERK-RSK-Elk-1 signaling pathway in prostate cancer cells.
Koochekpour S; Sartor O; Lee TJ; Zieske A; Patten DY; Hiraiwa M; Sandhoff K; Remmel N; Minokadeh A
Prostate; 2004 Oct; 61(2):114-23. PubMed ID: 15305334
[TBL] [Abstract][Full Text] [Related]
23. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator.
Nishimura K; Ting HJ; Harada Y; Tokizane T; Nonomura N; Kang HY; Chang HC; Yeh S; Miyamoto H; Shin M; Aozasa K; Okuyama A; Chang C
Cancer Res; 2003 Aug; 63(16):4888-94. PubMed ID: 12941811
[TBL] [Abstract][Full Text] [Related]
24. Androgen receptor expression in androgen-independent prostate cancer cell lines.
Chlenski A; Nakashiro K; Ketels KV; Korovaitseva GI; Oyasu R
Prostate; 2001 Apr; 47(1):66-75. PubMed ID: 11304731
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
Zhao XY; Malloy PJ; Krishnan AV; Swami S; Navone NM; Peehl DM; Feldman D
Nat Med; 2000 Jun; 6(6):703-6. PubMed ID: 10835690
[TBL] [Abstract][Full Text] [Related]
26. Methoxyacetic acid disregulation of androgen receptor and androgen-binding protein expression in adult rat testis.
Tirado OM; Martinez ED; Rodriguez OC; Danielsen M; Selva DM; Reventós J; Munell F; Suárez-Quian CA
Biol Reprod; 2003 Apr; 68(4):1437-46. PubMed ID: 12606434
[TBL] [Abstract][Full Text] [Related]
27. Androgen induction of in vitro prostate cell differentiation.
Whitacre DC; Chauhan S; Davis T; Gordon D; Cress AE; Miesfeld RL
Cell Growth Differ; 2002 Jan; 13(1):1-11. PubMed ID: 11801526
[TBL] [Abstract][Full Text] [Related]
28. Proteomic identification of 14-3-3 sigma as a common component of the androgen receptor and the epidermal growth factor receptor signaling pathways of the human prostate epithelial cell line M12.
Huang D; Liu X; Plymate SR; Idowu M; Grimes M; Best AM; McKinney JL; Ware JL
Oncogene; 2004 Sep; 23(41):6881-9. PubMed ID: 15300238
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer.
Hammacher A; Thompson EW; Williams ED
Int J Biochem Cell Biol; 2005 Feb; 37(2):442-50. PubMed ID: 15474988
[TBL] [Abstract][Full Text] [Related]
30. Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease.
Ricciardelli C; Choong CS; Buchanan G; Vivekanandan S; Neufing P; Stahl J; Marshall VR; Horsfall DJ; Tilley WD
Prostate; 2005 Apr; 63(1):19-28. PubMed ID: 15378523
[TBL] [Abstract][Full Text] [Related]
31. Regulation of androgen and vitamin d receptors by 1,25-dihydroxyvitamin D3 in human prostate epithelial and stromal cells.
Leman ES; DeMiguel F; Gao AC; Getzenberg RH
J Urol; 2003 Jul; 170(1):235-40. PubMed ID: 12796696
[TBL] [Abstract][Full Text] [Related]
32. The nongenotropic synthetic ligand 4-estren-3alpha17beta-diol is a high-affinity genotropic androgen receptor agonist.
Krishnan V; Bullock HA; Yaden BC; Liu M; Barr RJ; Montrose-Rafizadeh C; Chen K; Dodge JA; Bryant HU
Mol Pharmacol; 2005 Mar; 67(3):744-8. PubMed ID: 15557561
[TBL] [Abstract][Full Text] [Related]
33. Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer.
Kuniyasu H; Chihara Y; Kondo H; Ohmori H; Ukai R
Oncol Rep; 2003; 10(6):1863-8. PubMed ID: 14534709
[TBL] [Abstract][Full Text] [Related]
34. Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy.
Van der Kwast TH; Têtu B; Fradet Y; Dupont A; Gomez J; Cusan L; Diamond P; Labrie F
Prostate; 1996 Apr; 28(4):227-31. PubMed ID: 8602398
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a stromal cell model of the human benign and malignant prostate from explant culture.
Planz B; Kirley SD; Wang Q; Tabatabaei S; Aretz HT; McDougal WS
J Urol; 1999 Apr; 161(4):1329-36. PubMed ID: 10081903
[TBL] [Abstract][Full Text] [Related]
36. The androgen receptor mRNA.
Yeap BB; Wilce JA; Leedman PJ
Bioessays; 2004 Jun; 26(6):672-82. PubMed ID: 15170865
[TBL] [Abstract][Full Text] [Related]
37. Effects of 1,25-dihydroxyvitamin D3 on the distribution of androgen and vitamin D receptors in human prostate neonatal epithelial cells.
Leman ES; Getzenberg RH
J Cell Biochem; 2003 Feb; 88(3):609-22. PubMed ID: 12532336
[TBL] [Abstract][Full Text] [Related]
38. [Differential regulation of androgen receptor promoter in hormone-sensitive and -insensitive prostate carcinoma cells].
Kopp H; Masters JR; Wieland W; Hofstaedter F; Buettner R
Verh Dtsch Ges Pathol; 1993; 77():129-32. PubMed ID: 7511270
[TBL] [Abstract][Full Text] [Related]
39. Expression and function of androgen receptor in carcinoma of the prostate.
Culig Z; Hobisch A; Bartsch G; Klocker H
Microsc Res Tech; 2000 Dec; 51(5):447-55. PubMed ID: 11074615
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta is an autocrine mitogen for a novel androgen-responsive murine prostatic smooth muscle cell line, PSMC1.
Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
J Cell Physiol; 2000 Dec; 185(3):416-24. PubMed ID: 11056012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
